Compare AR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AR | PEN |
|---|---|---|
| Founded | 2002 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 12.8B |
| IPO Year | 2013 | 2015 |
| Metric | AR | PEN |
|---|---|---|
| Price | $36.95 | $319.18 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 16 |
| Target Price | $47.13 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 4.0M | 391.9K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1027.78 | ★ 1155.56 |
| EPS | ★ 1.72 | 0.82 |
| Revenue | ★ $5,275,823,000.00 | $1,403,665,000.00 |
| Revenue This Year | $29.74 | $14.34 |
| Revenue Next Year | $5.07 | $13.71 |
| P/E Ratio | ★ $20.71 | $388.48 |
| Revenue Growth | ★ 21.97 | 17.50 |
| 52 Week Low | $29.10 | $221.26 |
| 52 Week High | $45.75 | $362.41 |
| Indicator | AR | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 33.73 |
| Support Level | $35.47 | $302.19 |
| Resistance Level | $38.67 | $321.38 |
| Average True Range (ATR) | 1.08 | 2.72 |
| MACD | -0.08 | -0.44 |
| Stochastic Oscillator | 48.24 | 10.96 |
Antero Resources is an exploration and production firm whose operations represent a pure play in the Marcellus Shale, located in northern West Virginia. The company started in 2002 as an E&P focused on the Barnett Shale (Fort Worth, Texas). Antero redefined itself in Appalachia's Marcellus Shale in 2005. In 2012, shortly before Antero's 2013 IPO, Antero Midstream Partners was formed to handle the company's rapidly growing gas volumes. In 2026, the firm narrowed its focus further by selling its Ohio Utica assets and using the proceeds to acquire additional Marcellus acreage from HG Energy. Just over half of its production and earning power is tied to natural gas, with the remainder mostly NGLs, where it holds a leading position, and some crude oil.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.